Order results by:
| Issue | Title | |
| Vol 13, No 1 (2024) | Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia) | Abstract PDF (Rus) similar documents |
| T. N. Komarov, N. S. Bagaeva, K. K. Karnakova, K. Ya. Zaslavskaya, P. A. Bely, I. E. Shohin | ||
| "... Introduction. The pandemic of the new coronavirus infection COVID-19 (Coronavirus Disease 2019 ..." | ||
| Vol 13, No 1 (2024) | Phase I Pharmacokinetics Study of Drug Areplivir® Zinc (INN: Favipiravir + Zinc Gluconate) (LLC "PROMOMED RUS", Russia) | Abstract PDF (Rus) similar documents |
| T. N. Komarov, N. S. Bagaeva, K. K. Karnakova, O. A. Archakova, D. S. Shchelgacheva, V. S. Shcherbakova, K. Ya. Zaslavskaya, P. A. Bely, A. V. Taganov, I. E. Shohin | ||
| "... . This combination of favipiravir and zinc gluconate could provide more effective treatment of COVID-19. Aim ..." | ||
| Vol 13, No 1 (2024) | Reciprocal Impact of Molnupiravir and Favipiravir Monocomponents of the Combination Drug on Each Other's Pharmacokinetics in a Phase I Clinical Trial | Abstract PDF (Eng) similar documents |
| T. N. Komarov, K. K. Karnakova, N. S. Bagaeva, O. A. Archakova, M. O. Popova, V. S. Shcherbakova, K. Ya. Zaslavskaya, P. A. Bely, I. E. Shohin | ||
| "... Introduction. COVID-19 (Coronavirus disease 2019) almost 4 years after he start of the pandemic ..." | ||
| Vol 12, No 2 (2023) | Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC "PROMOMED RUS", Russia) | Abstract PDF (Rus) similar documents |
| T. N. Komarov, N. S. Bagaeva, K. K. Karnakova, I. E. Shohin, K. Ya. Zaslavskaya, P. A. Bely | ||
| "... Introduction. The novel coronavirus infection COVID-19 (Coronavirus Disease 2019) is caused ..." | ||
| Vol 13, No 1 (2024) | Development and Validation of an HPLC-MS/MS Method for Quantification of Apixaban in Human Plasma | Abstract PDF (Eng) similar documents |
| U. D. Filonova, P. K. Karnakova, K. K. Karnakova, M. O. Popova, A. A. Popova, O. A. Archakova, T. N. Komarov, I. E. Shohin | ||
| "... as antithrombotic therapy in patients with COVID-19, an increase in its use has been observed. Thus, due ..." | ||
| Vol 11, No 3 (2022) | Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma | Abstract PDF (Eng) similar documents |
| T. N. Komarov, P. K. Karnakova, O. A. Archakova, D. S. Shchelgacheva, N. S. Bagaeva, I. E. Shohin, K. Ya. Zaslavskaya, P. A. Bely | ||
| "... Introduction. Coronavirus disease (COVID-19) is an acute infectious disease caused by SARS-CoV-2 ..." | ||
| Vol 12, No 3 (2023) | Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS | Abstract PDF (Eng) similar documents |
| T. N. Komarov, P. A. Karpova, O. A. Archakova, D. S. Shchelgacheva, P. K. Karnakova, N. S. Bagaeva, K. Ya. Zaslavskaya, P. A. Bely, I. E. Shohin | ||
| Vol 12, No 2 (2023) | Simultaneous Determination of Nirmatrelvir and Ritonavir in Human Plasma by HPLC-MS/MS | Abstract PDF (Eng) similar documents |
| T. N. Komarov, P. K. Karnakova, O. A. Archakova, D. S. Shchelgacheva, N. S. Bagaeva, I. E. Shohin, K. Ya. Zaslavskaya, P. A. Bely | ||
| "... to remain a persistent global threat. Therefore, development of coronavirus disease 2019 (COVID-19) drugs ..." | ||
| Vol 12, No 1 (2023) | Simultaneous Determination of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) and Favipiravir in Human Plasma by HPLC-MS/MS | Abstract PDF (Eng) similar documents |
| T. N. Komarov, P. K. Karnakova, O. A. Archakova, D. S. Shchelgacheva, N. S. Bagaeva, I. E. Shohin, K. Ya. Zaslavskaya, P. A. Bely | ||
| "... Introduction. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the SARS-CoV ..." | ||
| 1 - 9 of 9 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
